Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Cillo

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.
Annals of Surgical Oncology|February 1, 2020
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center StudyJun Li, Mohamed Moustafa, Michael Linecker, et al.
BMC Cancer|May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaAndreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Journal of Hepatology|January 23, 2023
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosisYiliam Fundora, Amelia J Hessheimer, Luca Del Prete, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
Annals of Surgery|August 10, 2022
An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS)Burak Görgec, Andrea Benedetti Cacciaguerra, Timothy M Pawlik, et al.
BJS Open|November 28, 2025
Laparoscopic versus open liver resection in patients aged at least 80 years: retrospective propensity score-matched cohort studyConcepción Gómez-Gavara, Zenichi Morise, Victor López-López, et al.
JHEP Reports : Innovation in Hepatology|September 16, 2024
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry studyAlessandro Vitale, Silvia Trapani, Francesco Paolo Russo, et al.
Frontiers in Immunology|July 20, 2023
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipientsMaria Rendina, Michele Barone, Chiara Lillo, et al.
Annals of Surgery|March 14, 2024
Robotic Versus Laparoscopic Liver Resection in Various Settings: An International Multicenter Propensity Score Matched Study of 10.075 PatientsJasper P Sijberden, Tijs J Hoogteijling, Davit Aghayan, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.
Annals of Surgical Oncology|February 1, 2020
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center StudyJun Li, Mohamed Moustafa, Michael Linecker, et al.
BMC Cancer|May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaAndreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Journal of Hepatology|January 23, 2023
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosisYiliam Fundora, Amelia J Hessheimer, Luca Del Prete, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
Annals of Surgery|August 10, 2022
An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS)Burak Görgec, Andrea Benedetti Cacciaguerra, Timothy M Pawlik, et al.
BJS Open|November 28, 2025
Laparoscopic versus open liver resection in patients aged at least 80 years: retrospective propensity score-matched cohort studyConcepción Gómez-Gavara, Zenichi Morise, Victor López-López, et al.
JHEP Reports : Innovation in Hepatology|September 16, 2024
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry studyAlessandro Vitale, Silvia Trapani, Francesco Paolo Russo, et al.
Frontiers in Immunology|July 20, 2023
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipientsMaria Rendina, Michele Barone, Chiara Lillo, et al.
Annals of Surgery|March 14, 2024
Robotic Versus Laparoscopic Liver Resection in Various Settings: An International Multicenter Propensity Score Matched Study of 10.075 PatientsJasper P Sijberden, Tijs J Hoogteijling, Davit Aghayan, et al.
Pageof 41